Cell and Gene Therapy Catapult in new stem-cell deal – PharmaTimes
PharmaTimes |
Cell and Gene Therapy Catapult in new stem–cell deal
PharmaTimes The Cell and Gene Therapy Catapult (CGT Catapult) will provide its clinical-grade induced Pluripotent Stem Cell (iPSC) line to Seattle based Universal Cells for use in the development of its universal donor cell line. “Induced Pluripotent Stem Cell … CGT Catapult's iPSC line licensed to Universal Cells for creating universal donor cell line |
